Life Sciences
Synairgen plc
Year
2018
Transaction type
Equity Capital Markets & Corporate Broking
Sector
Life Sciences
finnCap have advised Synairgen plc (AIM: SNG) (“Synairgen”), the respiratory drug discovery and development company on their £2.9m fundraising.
Follow us
Related News
Leveraging the UK’s Healthcare & Life Science Sector
August 19, 2024
AI Strategy and Guidance
July 24, 2024
Update to the QCA Code
July 2, 2024
Shareholder Activism and Engagement
July 2, 2024
Sector Update – Technology
June 29, 2024
Meet the New Chair of the AIC
June 27, 2024